The five research categories, and what distinguishes them

The catalogue is grouped into five categories. The grouping is a navigation aid rather than a scientific taxonomy — several compounds sit in more than one box — but it maps onto receptor families closely enough to be useful, and it is the fastest way to narrow a broad research question into a shortlist.

Recovery & repair

Peptides studied in the context of soft-tissue repair, largely because of their activity in animal models of ligament, tendon and gut injury. BPC-157 is the most widely referenced, and the Repair Stack Blend combines it with a GH-axis component. The category name describes the research area, not a clinical claim.

Growth & performance

Growth-hormone secretagogues and their analogues — peptides studied for their effect on GH release and downstream signalling. They split into two groups: GHRP-class agonists such as GHRP-2, and the GHRH analogues such as CJC-1295 and the modified GRF fragment. Ipamorelin is a selective member of this group, and HGH Fragment 176-191 is the C-terminal fragment studied for activity without full GH release.

Metabolic & GLP-1

Receptor agonists studied in metabolic research, dominated by the incretin mimetics. Semaglutide and Tirzepatide are the two long-acting GLP-1-class agents here, and AOD-9604 is studied for a different receptor interaction. Semaglutide and tirzepatide are the two products where stereochemistry is essential to identity, so their mass spec confirmation matters more than most.

Longevity & cognitive

The most heterogeneous category: Epithalon (a synthetic tetrapeptide), the anxiolytic peptide Selank, and NAD+ as a cofactor rather than a peptide at all. Each is stable, small and inexpensive to make, which is why they are frequently chosen as synthesis and QC training material.

Tanning

Melanocortin receptor agonists, chiefly Melanotan II, studied for pigmentary effects via MC1R. Melanotan II carries a well-documented phototoxicity profile, which is the reason this category has its own COA emphasis.

Where the categories overlap

Two overlaps come up repeatedly. Repair peptides and GH-axis peptides are studied together often enough that we sell them as a combined repair-stack. And CJC-1295 without its DAC modification occupies an awkward spot — the non-DAC form is short-lived, which is exactly what the longer-acting variants were developed to address, so the two are usually discussed as a pair rather than as separate products.

The practical point: a category is a starting position for research, not a boundary. If you arrive at a question from the receptor side rather than the compound side, browse the full catalogue and filter by the family you are working with.